{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "Parkinson", "brain", "herbal medicine", "licorice"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36950127", "DateRevised": {"Year": "2023", "Month": "03", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "03", "Day": "06"}], "Language": ["eng"], "ELocationID": ["1148258", "10.3389/fnins.2023.1148258"], "Journal": {"ISSN": "1662-4548", "JournalIssue": {"Volume": "17", "PubDate": {"Year": "2023"}}, "Title": "Frontiers in neuroscience", "ISOAbbreviation": "Front Neurosci"}, "ArticleTitle": "A mechanistic review of pharmacological activities of homeopathic medicine licorice against neural diseases.", "Pagination": {"StartPage": "1148258", "MedlinePgn": "1148258"}, "Abstract": {"AbstractText": ["The use of medicinal plants has grown in popularity in recent decades because, as natural ingredients, they have fewer adverse effects and are more effective than synthetic alternatives. As a small perennial herb, <i>Glycyrrhiza glabra</i> L. (Licorice) has been investigated for its therapeutic efficacy against neural disorders mainly ischemic stroke as well as the neurodegenerative diseases such as dementia and Alzheimer's disease, and Parkinson's disease which has been attributed to its HMGB inhibitory function, reactive oxygen scavenging and anti-inflammatory activity. The objective of current review is to review the evidence for the pharmacological effects of licorice and its vital active components on neurological disorders and the underlying signaling networks. We reviewed Papers published from 2000.1.1 up to 2 January 2023 in web of science, Google Scholar and PubMed data bases using key words including \"Licorice,\" \"<i>Glycyrrhiza glabra</i> L.,\" \"Glycyrrhizic acid,\" \"brain,\" \"neurodegenerative disease,\" \"Alzheimer's,\" and \"Parkinson\" were used to search in title/abstracts. Licorice extract and/or its active components can be used safely in therapeutic doses for optimizing the management of a multiple neurodegenerative disorders, and hampering the extent of neural tissue injury and neurologic deficits subsequent to cerebrovascular accidents."], "CopyrightInformation": "Copyright \u00a9 2023 Zulfugarova, Zivari-Ghader, Maharramova, Ahmadian, Eftekhari, Khalilov, Turksoy, Rosi\u0107 and Selakovic."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology and Physiology, Faculty of Biology, Baku State University, Baku, Azerbaijan."}], "LastName": "Zulfugarova", "ForeName": "Parvin", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Zivari-Ghader", "ForeName": "Tayebeh", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Technology and Management, Azerbaijan Medical University, Baku, Azerbaijan."}], "LastName": "Maharramova", "ForeName": "Sevinj", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Ahmadian", "ForeName": "Elham", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Science, Ege University, \u0130zmir, Turkey."}, {"Identifier": [], "Affiliation": "Institute of Molecular Biology and Biotechnologies, Ministry of Science and Education Republic of Azerbaijan, Baku, Azerbaijan."}, {"Identifier": [], "Affiliation": "Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Eftekhari", "ForeName": "Aziz", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biophysics and Biochemistry, Baku State University, Baku, Azerbaijan."}], "LastName": "Khalilov", "ForeName": "Rovshan", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Public Health, Faculty of Medicine, Bozok University, Yozgat, Turkey."}], "LastName": "Turksoy", "ForeName": "Vugar Ali", "Initials": "VA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia."}], "LastName": "Rosi\u0107", "ForeName": "Gvozden", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia."}], "LastName": "Selakovic", "ForeName": "Dragica", "Initials": "D"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Neurosci", "NlmUniqueID": "101478481", "ISSNLinking": "1662-453X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abduljawad A., Elawad M., Elkhalifa M., Ahmed A., Hamdoon A., Salim L., et al. (2022). Alzheimer\u2019s disease as a major public health concern: Role of dietary saponins in mitigating neurodegenerative disorders and their underlying mechanisms. Molecules 27:6804. 10.3390/molecules27206804", "ArticleIdList": ["10.3390/molecules27206804", "PMC9608803", "36296397"]}, {"Citation": "Ahn J. Y., Kim S., Jung S., Ha T. (2010). Effect of licorice (Glycyrrhiza uralensis Fisch) on amyloid-\u03b2-induced neurotoxicity in PC12 cells. Food Sci. Biotechnol. 19 1391\u20131395."}, {"Citation": "Angelopoulou E., Paudel Y., Piperi C. (2019). miR-124 and Parkinson\u2019s disease: A biomarker with therapeutic potential. Pharmacol. Res. 150:104515. 10.1016/j.phrs.2019.104515", "ArticleIdList": ["10.1016/j.phrs.2019.104515", "31707035"]}, {"Citation": "Angelopoulou E., Piperi C., Papavassiliou A. (2018). High-mobility group box 1 in Parkinson\u2019s disease: From pathogenesis to therapeutic approaches. J. Neurochem. 146 211\u2013218. 10.1111/jnc.14450", "ArticleIdList": ["10.1111/jnc.14450", "29676481"]}, {"Citation": "Asl M., Hosseinzadeh H. (2008). Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother. Res. 22 709\u2013724. 10.1002/ptr.2362", "ArticleIdList": ["10.1002/ptr.2362", "PMC7167813", "18446848"]}, {"Citation": "Ayeka P., Bian Y., Mwitari P., Chu X., Zhang Y., Uzayisenga R., et al. (2016). Immunomodulatory and anticancer potential of Gan cao (Glycyrrhiza uralensis Fisch.) polysaccharides by CT-26 colon carcinoma cell growth inhibition and cytokine IL-7 upregulation in vitro. BMC Complement. Altern. Med. 16:206. 10.1186/s12906-016-1171-4", "ArticleIdList": ["10.1186/s12906-016-1171-4", "PMC4940688", "27401917"]}, {"Citation": "Barakat W., Safwet N., El-Maraghy N., Zakaria M. (2014). Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade. Eur. J. Pharmacol. 724 43\u201350. 10.1016/j.ejphar.2013.12.032", "ArticleIdList": ["10.1016/j.ejphar.2013.12.032", "24378346"]}, {"Citation": "Baran A., Bulut M., Kaya M., Demirpen\u00e7e \u00d6, Sevim B., Ak\u0131l E., et al. (2019). High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson\u2019s disease. Neurol. Sci. 40 167\u2013173. 10.1007/s10072-018-3611-z", "ArticleIdList": ["10.1007/s10072-018-3611-z", "30353300"]}, {"Citation": "Barman A., Chatterjee A., Bhide R. (2016). Cognitive impairment and rehabilitation strategies after traumatic brain injury. Indian J. Psychol. Med. 38 172\u2013181. 10.4103/0253-7176.183086", "ArticleIdList": ["10.4103/0253-7176.183086", "PMC4904751", "27335510"]}, {"Citation": "Cai Z., Liu N., Wang C., Qin B., Zhou Y., Xiao M., et al. (2016). Role of RAGE in Alzheimer\u2019s disease. Cell Mol. Neurobiol. 36 483\u2013495. 10.1007/s10571-015-0233-3", "ArticleIdList": ["10.1007/s10571-015-0233-3", "26175217"]}, {"Citation": "Chen M., Zhu J., Kang J., Lai X., Gao Y., Gan H., et al. (2019). Exploration in the mechanism of action of licorice by network pharmacology. Molecules 24:2959. 10.3390/molecules24162959", "ArticleIdList": ["10.3390/molecules24162959", "PMC6720938", "31443210"]}, {"Citation": "Cherng J., Lin H., Hung M., Lin Y., Chan M., Lin J. (2006). Inhibition of nuclear factor kappaB is associated with neuroprotective effects of glycyrrhizic acid on glutamate-induced excitotoxicity in primary neurons. Eur. J. Pharmacol. 547 10\u201321. 10.1016/j.ejphar.2006.06.080", "ArticleIdList": ["10.1016/j.ejphar.2006.06.080", "16952351"]}, {"Citation": "Choi M., Lim C., Lee B., Cho S. (2022). Amelioration of brain damage after treatment with the methanolic extract of glycyrrhizae radix et rhizoma in mice. Pharmaceutics 14:2776. 10.3390/pharmaceutics14122776", "ArticleIdList": ["10.3390/pharmaceutics14122776", "PMC9781260", "36559268"]}, {"Citation": "Colovi\u00e6 M., Krsti\u00e6 D., Lazarevi\u00e6-Pa\u0161ti T., Bond\u017ei\u00e6 A., Vasi\u00e6 V. (2013). Acetylcholinesterase inhibitors: Pharmacology and toxicology. Curr. Neuropharmacol. 11 315\u2013335. 10.2174/1570159X11311030006", "ArticleIdList": ["10.2174/1570159X11311030006", "PMC3648782", "24179466"]}, {"Citation": "Cosmetic Ingredient Review Expert Panel. (2007). Final report on the safety assessment of glycyrrhetinic acid, potassium glycyrrhetinate, disodium succinoyl glycyrrhetinate, glyceryl glycyrrhetinate, glycyrrhetinyl stearate, stearyl glycyrrhetinate, glycyrrhizic acid, ammonium glycyrrhizate, dipotassium glycyrrhizate, disodium glycyrrhizate, trisodium glycyrrhizate, methyl glycyrrhizate, and potassium glycyrrhizinate. Int. J. Toxicol. 26(Suppl. 2) 79\u2013112. 10.1080/10915810701351228", "ArticleIdList": ["10.1080/10915810701351228", "17613133"]}, {"Citation": "Costello D., Watson M., Cowley T., Murphy N., Murphy Royal C., Garlanda C., et al. (2011). Interleukin-1alpha and HMGB1 mediate hippocampal dysfunction in SIGIRR-deficient mice. J. Neurosci. 31 3871\u20133879. 10.1523/JNEUROSCI.6676-10.2011", "ArticleIdList": ["10.1523/JNEUROSCI.6676-10.2011", "PMC6622806", "21389242"]}, {"Citation": "Cui Y., Ao M., Li W., Yu L. (2008). Effect of glabridin from Glycyrrhiza glabra on learning and memory in mice. Planta Med. 74 377\u2013380. 10.1055/s-2008-1034319", "ArticleIdList": ["10.1055/s-2008-1034319", "18484526"]}, {"Citation": "Dai X., Li H., Lu C., Wang J., Dong J., Wei J., et al. (2013). Liquiritigenin prevents Staphylococcus aureus-mediated lung cell injury via inhibiting the production of \u03b1-hemolysin. J. Asian Nat. Prod. Res. 15 390\u2013399. 10.1080/10286020.2013.771344", "ArticleIdList": ["10.1080/10286020.2013.771344", "23464667"]}, {"Citation": "DeLong J., Ohashi S., O\u2019Connor K., Sansing L. (2022). Inflammatory responses after ischemic stroke. Semin. Immunopathol. 44 625\u2013648. 10.1007/s00281-022-00943-7", "ArticleIdList": ["10.1007/s00281-022-00943-7", "35767089"]}, {"Citation": "Dezsi L., Vecsei L. (2017). Monoamine oxidase b inhibitors in Parkinson\u2019s disease. CNS Neurol. Disord Drug Targets 16 425\u2013439. 10.2174/1871527316666170124165222", "ArticleIdList": ["10.2174/1871527316666170124165222", "28124620"]}, {"Citation": "Dhingra D., Parle M., Kulkarni S. (2004). Memory enhancing activity of Glycyrrhiza glabra in mice. J. Ethnopharmacol. 91 361\u2013365. 10.1016/j.jep.2004.01.016", "ArticleIdList": ["10.1016/j.jep.2004.01.016", "15120462"]}, {"Citation": "Fu Y., Chen J., Li Y., Zheng Y., Li P. (2013). Antioxidant and anti-inflammatory activities of six flavonoids separated from licorice. Food Chem. 141 1063\u20131071. 10.1016/j.foodchem.2013.03.089", "ArticleIdList": ["10.1016/j.foodchem.2013.03.089", "23790887"]}, {"Citation": "Gao L., Wang X., Niu Y., Duan D., Yang X., Hao J., et al. (2016). Molecular targets of Chinese herbs: A clinical study of hepatoma based on network pharmacology. Sci. Rep. 6 24944. 10.1038/srep24944", "ArticleIdList": ["10.1038/srep24944", "PMC4855233", "27143508"]}, {"Citation": "Gao T., Chen Z., Chen H., Yuan H., Wang Y., Peng X., et al. (2018). Inhibition of HMGB1 mediates neuroprotection of traumatic brain injury by modulating the microglia/macrophage polarization. Biochem. Biophys. Res. Commun. 497 430\u2013436. 10.1016/j.bbrc.2018.02.102", "ArticleIdList": ["10.1016/j.bbrc.2018.02.102", "29448108"]}, {"Citation": "Gaur R., Yadav K., Verma R., Yadav N., Bhakuni R. (2014). In vivo anti-diabetic activity of derivatives of isoliquiritigenin and liquiritigenin. Phytomedicine 21 415\u2013422. 10.1016/j.phymed.2013.10.015", "ArticleIdList": ["10.1016/j.phymed.2013.10.015", "24262065"]}, {"Citation": "Gong G., Xiang L., Yuan L., Hu L., Wu W., Cai L., et al. (2014). Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats. PLoS One 9:e89450. 10.1371/journal.pone.0089450", "ArticleIdList": ["10.1371/journal.pone.0089450", "PMC3942385", "24594628"]}, {"Citation": "Gu X., Xu J., Ma B., Chen G., Gu P., Wei D., et al. (2014). Effect of glycyrrhizin on traumatic brain injury in rats and its mechanism. Chin. J. Traumatol. 17 1\u20137.", "ArticleIdList": ["24506915"]}, {"Citation": "Guo J., Yang C., Yang J., Yao Y. (2016). Glycyrrhizic acid ameliorates cognitive impairment in a rat model of vascular dementia associated with oxidative damage and inhibition of voltage-gated sodium channels. CNS Neurol. Disord. Drug Targets 15 1001\u20131008. 10.2174/1871527315666160527163526", "ArticleIdList": ["10.2174/1871527315666160527163526", "27238153"]}, {"Citation": "Han S., Sun L., He F., Che H. (2017). Anti-allergic activity of glycyrrhizic acid on IgE-mediated allergic reaction by regulation of allergy-related immune cells. Sci. Rep. 7 7222. 10.1038/s41598-017-07833-1", "ArticleIdList": ["10.1038/s41598-017-07833-1", "PMC5543155", "28775294"]}, {"Citation": "Hasanein P. (2011). Glabridin as a major active isoflavan from Glycyrrhiza glabra (licorice) reverses learning and memory deficits in diabetic rats. Acta Physiol. Hung. 98 221\u2013230. 10.1556/APhysiol.98.2011.2.14", "ArticleIdList": ["10.1556/APhysiol.98.2011.2.14", "21616781"]}, {"Citation": "Hassan S., Abdel-Daim M., Behl T., Bungau S. (2022a). Natural products for chronic diseases: A ray of hope. Molecules 27:5573. 10.3390/molecules27175573", "ArticleIdList": ["10.3390/molecules27175573", "PMC9457656", "36080344"]}, {"Citation": "Hassan S., Samanta S., Dash R., Karpi\u00f1ski T., Habibi E., Sadiq A., et al. (2022b). The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress. Front. Pharmacol. 13:1015835. 10.3389/fphar.2022.1015835", "ArticleIdList": ["10.3389/fphar.2022.1015835", "PMC9589363", "36299900"]}, {"Citation": "Hatano T., Fukuda T., Miyase T., Noro T., Okuda T. (1991). Phenolic constituents of licorice. III. Structures of glicoricone and licofuranone, and inhibitory effects of licorice constituents on monoamine oxidase. Chem. Pharm. Bull. (Tokyo) 39 1238\u20131243. 10.1248/cpb.39.1238", "ArticleIdList": ["10.1248/cpb.39.1238", "1913999"]}, {"Citation": "Hay J., Johnson V., Smith D., Stewart W. (2016). Chronic traumatic encephalopathy: The neuropathological legacy of traumatic brain injury. Annu. Rev. Pathol. 11 21\u201345. 10.1146/annurev-pathol-012615-044116", "ArticleIdList": ["10.1146/annurev-pathol-012615-044116", "PMC5367053", "26772317"]}, {"Citation": "Hei Y., Chen R., Yi X., Long Q., Gao D., Liu W. (2018). HMGB1 neutralization attenuates hippocampal neuronal death and cognitive impairment in rats with chronic cerebral hypoperfusion via suppressing inflammatory responses and oxidative stress. Neuroscience 383 150\u2013159. 10.1016/j.neuroscience.2018.05.010", "ArticleIdList": ["10.1016/j.neuroscience.2018.05.010", "29777754"]}, {"Citation": "Heidari S., Mehri S., Hosseinzadeh H. (2021). The genus Glycyrrhiza (Fabaceae family) and its active constituents as protective agents against natural or chemical toxicities. Phytother. Res. 35 6552\u20136571. 10.1002/ptr.7238", "ArticleIdList": ["10.1002/ptr.7238", "34414608"]}, {"Citation": "Hopkins A. (2007). Network pharmacology. Nat. Biotechnol. 25 1110\u20131111. 10.1038/nbt1007-1110", "ArticleIdList": ["10.1038/nbt1007-1110", "17921993"]}, {"Citation": "Hopkins A. (2008). Network pharmacology: The next paradigm in drug discovery. Nat. Chem. Biol. 4 682\u2013690. 10.1038/nchembio.118", "ArticleIdList": ["10.1038/nchembio.118", "18936753"]}, {"Citation": "Hosseinzadeh H., Nassiri-Asl M. (2015). Pharmacological effects of Glycyrrhiza spp. and its bioactive constituents: Update and review. Phytother. Res. 29 1868\u20131886.", "ArticleIdList": ["26462981"]}, {"Citation": "Huang L., Lv Q., Xie D., Shi T., Wen C. (2016). Deciphering the potential pharmaceutical mechanism of chinese traditional medicine (Gui-Zhi-Shao-Yao-Zhi-Mu) on rheumatoid arthritis. Sci. Rep. 6:22602. 10.1038/srep22602", "ArticleIdList": ["10.1038/srep22602", "PMC4776278", "26935797"]}, {"Citation": "Hwang C., Chun H. (2012). Isoliquiritigenin isolated from licorice Glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons. Biosci. Biotechnol. Biochem. 76 536\u2013543. 10.1271/bbb.110842", "ArticleIdList": ["10.1271/bbb.110842", "22451397"]}, {"Citation": "Hwang I., Lim S., Choi K., Yoo K., Shin H., Kim E., et al. (2006). Neuroprotective effects of roasted licorice, not raw form, on neuronal injury in gerbil hippocampus after transient forebrain ischemia. Acta Pharmacol. Sin. 27 959\u2013965. 10.1111/j.1745-7254.2006.00346.x", "ArticleIdList": ["10.1111/j.1745-7254.2006.00346.x", "16867245"]}, {"Citation": "Isbrucker R., Burdock G. (2006). Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul. Toxicol. Pharmacol. 46 167\u2013192. 10.1016/j.yrtph.2006.06.002", "ArticleIdList": ["10.1016/j.yrtph.2006.06.002", "16884839"]}, {"Citation": "Jang A., Liew H., Kim Y., Choi H., Kim S., Lee S., et al. (2013). p35 deficiency accelerates HMGB-1-mediated neuronal death in the early stages of an Alzheimer\u2019s disease mouse model. Curr. Alzheimer Res. 10 829\u2013843. 10.2174/15672050113109990135", "ArticleIdList": ["10.2174/15672050113109990135", "23905994"]}, {"Citation": "Jiao Y., Song Y., Gao S. (2013). Research advances on production of flavonoids by licorice tissue culture. Plant Physiol. J. 49 13\u201318."}, {"Citation": "Kao T., Shyu M., Yen G. (2009). Neuroprotective effects of glycyrrhizic acid and 18beta-glycyrrhetinic acid in PC12 cells via modulation of the PI3K/Akt pathway. J. Agric. Food Chem. 57 754\u2013761. 10.1021/jf802864k", "ArticleIdList": ["10.1021/jf802864k", "19105645"]}, {"Citation": "Karthikkeyan G., Pervaje R., Pervaje S., Prasad T., Modi P. (2021). Prevention of MEK-ERK-1/2 hyper-activation underlines the neuroprotective effect of Glycyrrhiza glabra L. (Yashtimadhu) against rotenone-induced cellular and molecular aberrations. J. Ethnopharmacol. 274:114025. 10.1016/j.jep.2021.114025", "ArticleIdList": ["10.1016/j.jep.2021.114025", "33775804"]}, {"Citation": "Kim J., Kim J., Shim J., Lee S., Kim J., Lim S., et al. (2013). Licorice-derived dehydroglyasperin C increases MKP-1 expression and suppresses inflammation-mediated neurodegeneration. Neurochem. Int. 63 732\u2013740. 10.1016/j.neuint.2013.09.013", "ArticleIdList": ["10.1016/j.neuint.2013.09.013", "24083986"]}, {"Citation": "Kim S., Jin Y., Shin J., Kim I., Lee H., Park S., et al. (2012). Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion. Neurobiol. Dis. 46 147\u2013156. 10.1016/j.nbd.2011.12.056", "ArticleIdList": ["10.1016/j.nbd.2011.12.056", "22266336"]}, {"Citation": "Kim Y., Lee C. (2008). Glycyrrhizin attenuates MPTP neurotoxicity in mouse and MPP-induced cell death in PC12 cells. Korean J. Physiol. Pharmacol. 12 65\u201371. 10.4196/kjpp.2008.12.2.65", "ArticleIdList": ["10.4196/kjpp.2008.12.2.65", "PMC2817536", "20157396"]}, {"Citation": "Kirkeby A., Barker R. (2019). Parkinson disease and growth factors \u2013 is GDNF good enough? Nat. Rev. Neurol. 15 312\u2013314. 10.1038/s41582-019-0180-6", "ArticleIdList": ["10.1038/s41582-019-0180-6", "30948845"]}, {"Citation": "Kochanek P., Jackson T., Ferguson N., Carlson S., Simon D., Brockman E., et al. (2015). Emerging therapies in traumatic brain injury. Semin. Neurol. 35 83\u2013100. 10.1055/s-0035-1544237", "ArticleIdList": ["10.1055/s-0035-1544237", "PMC4356170", "25714870"]}, {"Citation": "Kong Z., Chen X., Hua H., Liang L., Liu L. (2017). The oral pretreatment of glycyrrhizin prevents surgery-induced cognitive impairment in aged mice by reducing neuroinflammation and Alzheimer\u2019s-related pathology via HMGB1 inhibition. J. Mol. Neurosci. 63 385\u2013395. 10.1007/s12031-017-0989-7", "ArticleIdList": ["10.1007/s12031-017-0989-7", "29034441"]}, {"Citation": "Lee H., Yang E., Kim J., Song K., Seong Y. (2012). Inhibitory effects of Glycyrrhizae radix and its active component, isoliquiritigenin, on A\u03b2(25-35)-induced neurotoxicity in cultured rat cortical neurons. Arch Pharm. Res. 35 897\u2013904. 10.1007/s12272-012-0515-y", "ArticleIdList": ["10.1007/s12272-012-0515-y", "22644857"]}, {"Citation": "Li M., Li H., Fang F., Deng X., Ma S. (2017). Astragaloside IV attenuates cognitive impairments induced by transient cerebral ischemia and reperfusion in mice via anti-inflammatory mechanisms. Neurosci. Lett. 639 114\u2013119. 10.1016/j.neulet.2016.12.046", "ArticleIdList": ["10.1016/j.neulet.2016.12.046", "28011393"]}, {"Citation": "Liao M., Zhao Y., Huang L., Cheng B., Huang K. (2016). Isoliquiritigenin and liquiritin from Glycyrrhiza uralensis inhibit \u03b1-synuclein amyloid formation. RSC Adv. 6 86640\u201386649."}, {"Citation": "Lim C., Lim S., Lee B., Kim B., Cho S. (2018). Licorice pretreatment protects against brain damage induced by middle cerebral artery occlusion in mice. J. Med. Food 21 474\u2013480. 10.1089/jmf.2017.4044", "ArticleIdList": ["10.1089/jmf.2017.4044", "29341803"]}, {"Citation": "Maas A., Stocchetti N., Bullock R. (2008). Moderate and severe traumatic brain injury in adults. Lancet Neurol. 7 728\u2013741. 10.1016/S1474-4422(08)70164-9", "ArticleIdList": ["10.1016/S1474-4422(08)70164-9", "18635021"]}, {"Citation": "Mahnashi M., Alshahrani M., Nahari M., Hassan S., Jan M., Ayaz M., et al. (2022). In-vitro, in-vivo, molecular docking and ADMET studies of 2-substituted 3,7-dihydroxy-4H-chromen-4-one for oxidative stress, inflammation and Alzheimer\u2019s disease. Metabolites 12:1055. 10.3390/metabo12111055", "ArticleIdList": ["10.3390/metabo12111055", "PMC9694897", "36355138"]}, {"Citation": "Miculas D., Negru P., Bungau S., Behl T., Hassan S., Tit D. (2022). Pharmacotherapy evolution in Alzheimer\u2019s disease: Current framework and relevant directions. Cells 12:131. 10.3390/cells12010131", "ArticleIdList": ["10.3390/cells12010131", "PMC9818415", "36611925"]}, {"Citation": "Ojha S., Javed H., Azimullah S., Abul Khair S., Haque M. (2016). Glycyrrhizic acid attenuates neuroinflammation and oxidative stress in rotenone model of parkinson\u2019s disease. Neurotox. Res. 29 275\u2013287. 10.1007/s12640-015-9579-z", "ArticleIdList": ["10.1007/s12640-015-9579-z", "26607911"]}, {"Citation": "Okuma Y., Wake H., Teshigawara K., Takahashi Y., Hishikawa T., Yasuhara T., et al. (2019). Anti-high mobility group box 1 antibody therapy may prevent cognitive dysfunction after traumatic brain injury. World Neurosurg. 122 e864\u2013e871. 10.1016/j.wneu.2018.10.164", "ArticleIdList": ["10.1016/j.wneu.2018.10.164", "30391757"]}, {"Citation": "Pang H., Huang T., Song J., Li D., Zhao Y., Ma X. (2016). Inhibiting HMGB1 with glycyrrhizic acid protects brain injury after DAI via its anti-inflammatory effect. Mediators Inflamm. 2016:4569521. 10.1155/2016/4569521", "ArticleIdList": ["10.1155/2016/4569521", "PMC4799817", "27041825"]}, {"Citation": "Parker T., Nguyen A., Rabang J., Patil A., Agrawal D. (2017). The danger zone: Systematic review of the role of HMGB1 danger signalling in traumatic brain injury. Brain Inj. 31 2\u20138. 10.1080/02699052.2016.1217045", "ArticleIdList": ["10.1080/02699052.2016.1217045", "PMC5610113", "27819487"]}, {"Citation": "Paudel Y., Angelopoulou E., Piperi C., Shaikh M., Othman I. (2020). Emerging neuroprotective effect of metformin in Parkinson\u2019s disease: A molecular crosstalk. Pharmacol. Res. 152:104593. 10.1016/j.phrs.2019.104593", "ArticleIdList": ["10.1016/j.phrs.2019.104593", "31843673"]}, {"Citation": "Peng F., Du Q., Peng C., Wang N., Tang H., Xie X., et al. (2015). A review: The pharmacology of isoliquiritigenin. Phytother. Res. 29 969\u2013977. 10.1002/ptr.5348", "ArticleIdList": ["10.1002/ptr.5348", "25907962"]}, {"Citation": "Ramalingam M., Kim H., Lee Y., Lee Y. (2018). Phytochemical and pharmacological role of liquiritigenin and isoliquiritigenin from radix Glycyrrhizae in human health and disease models. Front. Aging Neurosci. 10:348. 10.3389/fnagi.2018.00348", "ArticleIdList": ["10.3389/fnagi.2018.00348", "PMC6221911", "30443212"]}, {"Citation": "Ramsay R., Tipton K. (2017). Assessment of enzyme inhibition: A review with examples from the development of monoamine oxidase and cholinesterase inhibitory drugs. Molecules 22:1192. 10.3390/molecules22071192", "ArticleIdList": ["10.3390/molecules22071192", "PMC6152246", "28714881"]}, {"Citation": "Ravanfar P., Namazi G., Atigh M., Zafarmand S., Hamedi A., Salehi A., et al. (2016). Efficacy of whole extract of licorice in neurological improvement of patients after acute ischemic stroke. J. Herb. Med. 6 12\u201317."}, {"Citation": "Richard S., Min W., Su Z., Xu H. (2017). High mobility group box 1 and traumatic brain injury. J. Behav. Brain Sci. 7 50\u201361."}, {"Citation": "Roaldsen M., Lindekleiv H., Mathiesen E. (2021). Intravenous thrombolytic treatment and endovascular thrombectomy for ischaemic wake-up stroke. Cochrane Database Syst. Rev. 12:CD010995. 10.1002/14651858.CD010995.pub3", "ArticleIdList": ["10.1002/14651858.CD010995.pub3", "PMC8632645", "34850380"]}, {"Citation": "Rong X., Jiang L., Qu M., Hassan S., Liu Z. (2021). Enhancing therapeutic efficacy of donepezil by combined therapy: A comprehensive review. Curr. Pharm. Des. 27 332\u2013344. 10.2174/1381612826666201023144836", "ArticleIdList": ["10.2174/1381612826666201023144836", "33100197"]}, {"Citation": "Sathyamoorthy Y., Kaliappan K., Nambi P., Radhakrishnan R. (2020). Glycyrrhizic acid renders robust neuroprotection in rodent model of vascular dementia by controlling oxidative stress and curtailing cytochrome-c release. Nutr. Neurosci. 23 955\u2013970. 10.1080/1028415X.2019.1580935", "ArticleIdList": ["10.1080/1028415X.2019.1580935", "30794076"]}, {"Citation": "Shi H., Wu Y., Wang Y., Zhou M., Yan S., Chen Z., et al. (2015). Liquiritigenin potentiates the inhibitory effects of cisplatin on invasion and metastasis via downregulation MMP-2/9 and PI3 K/AKT signaling pathway in B16F10 melanoma cells and mice model. Nutr. Cancer 67 761\u2013770. 10.1080/01635581.2015.1037962", "ArticleIdList": ["10.1080/01635581.2015.1037962", "25978595"]}, {"Citation": "Shih R., Wang C., Yang C. M. (2015). NF-kappaB signaling pathways in neurological inflammation: A mini review. Front. Mol. Neurosci. 8:77. 10.3389/fnmol.2015.00077", "ArticleIdList": ["10.3389/fnmol.2015.00077", "PMC4683208", "26733801"]}, {"Citation": "Song J., Lee J., Shim B., Lee C., Choi S., Kang C., et al. (2013). Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice. Molecules 18 15788\u201315803. 10.3390/molecules181215788", "ArticleIdList": ["10.3390/molecules181215788", "PMC6269849", "24352029"]}, {"Citation": "Srinivasan M., Lahiri D. (2015). Significance of NF-\u03baB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer\u2019s disease and multiple sclerosis. Expert. Opin. Ther. Targets 19 471\u2013487. 10.1517/14728222.2014.989834", "ArticleIdList": ["10.1517/14728222.2014.989834", "PMC5873291", "25652642"]}, {"Citation": "Ton S. H., Chandramouli C., Bak K. (2013). \u201cGlycyrrhizic acid: Biological effects on glucose and lipid metabolism,\u201d in Natural products, eds Ramawat K., M\u00e9rillon J. (Berlin: Springer; ), 3803\u20133826."}, {"Citation": "van Gelderen C., Bijlsma J., van Dokkum W., Savelkoul T. (2000). Glycyrrhizic acid: the assessment of a no effect level. Hum. Exp. Toxicol. 19 434\u2013439. 10.1191/096032700682694251", "ArticleIdList": ["10.1191/096032700682694251", "11125713"]}, {"Citation": "Wang C., Kao T., Lo W., Yen G. (2011). Glycyrrhizic acid and 18\u03b2-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-\u03baB through PI3K p110\u03b4 and p110\u03b3 inhibitions. J. Agric. Food Chem. 59 7726\u20137733. 10.1021/jf2013265", "ArticleIdList": ["10.1021/jf2013265", "21644799"]}, {"Citation": "Wang D., Guo T., Wang Z., Lu J., Liu D., Meng Q., et al. (2014). ERKs and mitochondria-related pathways are essential for glycyrrhizic acid-mediated neuroprotection against glutamate-induced toxicity in differentiated PC12 cells. Braz. J. Med. Biol. Res. 47 773\u2013779. 10.1590/1414-431x20143760", "ArticleIdList": ["10.1590/1414-431x20143760", "PMC4143205", "25075574"]}, {"Citation": "Wang W., Chen X., Zhang J., Zhao Y., Li S., Tan L., et al. (2016). Glycyrrhizin attenuates isoflurane-induced cognitive deficits in neonatal rats via its anti-inflammatory activity. Neuroscience 316 328\u2013336. 10.1016/j.neuroscience.2015.11.001", "ArticleIdList": ["10.1016/j.neuroscience.2015.11.001", "26550949"]}, {"Citation": "Wang Z., Ding Y., Wang X., Lu S., Wang C., He C., et al. (2018). Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT. Cancer Lett. 428 21\u201333. 10.1016/j.canlet.2018.04.021", "ArticleIdList": ["10.1016/j.canlet.2018.04.021", "29702192"]}, {"Citation": "Webster K., Sun M., Crack P., O\u2019Brien T., Shultz S., Semple B. (2017). Inflammation in epileptogenesis after traumatic brain injury. J. Neuroinflammation 14:10. 10.1186/s12974-016-0786-1", "ArticleIdList": ["10.1186/s12974-016-0786-1", "PMC5237206", "28086980"]}, {"Citation": "Wei G., Da H., Zhang K., Zhang J., Fang J., Yang Z. (2021). Glycoside compounds from Glycyrrhiza uralensis and their neuroprotective activities. Nat. Product Commun. 16 10.1177/1934578X2199", "ArticleIdList": ["10.1177/1934578X2199"]}, {"Citation": "Woodcock T., Morganti-Kossmann M. (2013). The role of markers of inflammation in traumatic brain injury. Front Neurol. 4:18. 10.3389/fneur.2013.00018", "ArticleIdList": ["10.3389/fneur.2013.00018", "PMC3586682", "23459929"]}, {"Citation": "Xiong X., Gu L., Wang Y., Luo Y., Zhang H., Lee J., et al. (2016). Glycyrrhizin protects against focal cerebral ischemia via inhibition of T cell activity and HMGB1-mediated mechanisms. J. Neuroinflammation 13:241. 10.1186/s12974-016-0705-5", "ArticleIdList": ["10.1186/s12974-016-0705-5", "PMC5016958", "27609334"]}, {"Citation": "Yang H., Wang H., Czura C., Tracey K. (2005). The cytokine activity of HMGB1. J. Leukoc. Biol. 78 1\u20138. 10.1189/jlb.1104648", "ArticleIdList": ["10.1189/jlb.1104648", "15734795"]}, {"Citation": "Yang Y., Han C., Guo L., Guan Q. (2018). High expression of the HMGB1-TLR4 axis and its downstream signaling factors in patients with Parkinson\u2019s disease and the relationship of pathological staging. Brain Behav. 8:e00948. 10.1002/brb3.948", "ArticleIdList": ["10.1002/brb3.948", "PMC5893335", "29670828"]}, {"Citation": "Yim S., Park S., Lee C. (2007). Protective effect of glycyrrhizin on 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death in differentiated PC12 cells. J. Pharmacol. Exp. Ther. 321 816\u2013822. 10.1124/jpet.107.119602", "ArticleIdList": ["10.1124/jpet.107.119602", "17314199"]}, {"Citation": "Yu X., Xue C., Zhou Z., Li C., Du Y., Liang J., et al. (2008). In vitro and in vivo neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (licorice). Life Sci. 82 68\u201378. 10.1016/j.lfs.2007.10.019", "ArticleIdList": ["10.1016/j.lfs.2007.10.019", "18048062"]}, {"Citation": "Zhang J., Wu Y., Weng Z., Zhou T., Feng T., Lin Y. (2014). Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway. Brain Res. 1582 176\u2013186. 10.1016/j.brainres.2014.07.002", "ArticleIdList": ["10.1016/j.brainres.2014.07.002", "25111887"]}, {"Citation": "Zhu H., Hao J., Niu Y., Liu D., Chen D., Wu X. (2018). Molecular targets of Chinese herbs: A clinical study of metastatic colorectal cancer based on network pharmacology. Sci. Rep. 8 7238. 10.1038/s41598-018-25500-x", "ArticleIdList": ["10.1038/s41598-018-25500-x", "PMC5940835", "29740162"]}, {"Citation": "Zhu K., Zhu X., Liu S., Yu J., Wu S., Hei M. (2022). Glycyrrhizin attenuates hypoxic-ischemic brain damage by inhibiting ferroptosis and neuroinflammation in neonatal rats via the HMGB1/GPX4 pathway. Oxid. Med. Cell Longev. 2022:8438528. 10.1155/2022/8438528", "ArticleIdList": ["10.1155/2022/8438528", "PMC9010207", "35432719"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "19"}, {"Year": "2023", "Month": "2", "Day": "17"}, {"Year": "2023", "Month": "3", "Day": "23", "Hour": "2", "Minute": "21"}, {"Year": "2023", "Month": "3", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["36950127", "PMC10025333", "10.3389/fnins.2023.1148258"]}}], "PubmedBookArticle": []}